Evaluation of Sodium (23Na) MR-imaging as a Biomarker and Predictor for Neurodegenerative Changes in Patients With Alzheimers Disease

Conclusion: 23Na-MRI has the potential to be developed as a useful biomarker for the diagnosis of AD.

Source: In Vivo - January 5, 2021 Category: Research Authors: MOHAMED, S. A., HERRMANN, K., ADLUNG, A., PASCHKE, N., HAUSNER, L., FRÖLICH, L., SCHAD, L., GRODEN, C., KERL, H. U. Tags: Clinical Studies Source Type: research